Navigation Links
International Essential Tremor Foundation to Facilitate Essential Tremor Seminar in Los Angeles,Calif.
Date:10/28/2013

Lenexa, KS (PRWEB) October 29, 2013

The International Essential Tremor Foundation (IETF) will host a free seminar in Los Angeles, Calif. on the life-altering neurological condition called essential tremor (ET). The seminar will take place on Saturday, November 9, 2013 at Cedars-Sinai Medical Center’s Advanced Health Sciences Pavilion (Education Center Rooms 6 & 7) located at 127 South San Vicente Blvd in Los Angeles. The program will run from 9:30 - 11:30 a.m., with a question and answer session with the presenting physicians directly following the presentation. More information, including driving directions and event registration, is available by phone (toll-free) at 888.387.3667 or on the web at http://www.essentialtremor.org/seminars.

Essential tremor patients, family members, caregivers, and health care providers are invited to attend this special, free, educational seminar. Local physicians Michele Tagliati, MD, Director of Movement Disorders Program and Adam Mamelak, MD, Director of Functional Neurosurgery Program, are both with Cedars-Sinai Medical Center and will discuss the diagnosis process for essential tremor, commonly prescribed medications, surgical options, current scientific research, support groups and more. Attendees will be provided with an essential tremor information packet to take home and share with friends, family and their own health care providers. Refreshments will be served and parking is free.

“The IETF is dedicated to offering hope to those affected by essential tremor,” explains Catherine Rice, IETF executive director. “The Foundation actively works to generate greater awareness of the condition, fund critical scientific research in order to fully understand the causes of ET and offer support to those affected by this life-altering condition. At
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. International breast health global summit will focus on supportive care and quality of life
2. International conference to explore health of descendants of transatlantic slave trade
3. Kessler Foundation researchers present at first International Congress on Cognition in MS
4. Internationally known expert in ovarian cancer to be honored at the ASCO Annual Meeting
5. Nobel laureate to keynote international pharmaceutical conference at URI
6. International Nanomedicine Conference bound for Sydney: July 2-4, 2012
7. June 2012 marks a milestone for International Urogynecology Associates as Dr. Robert D. Moore and Dr. John R. Miklos perform their 24th Neovagina Surgery in 24 months
8. Heavy Duty Alternators and Starters Expert Elreg Distributors Ltd. Meets Needs of International Market with Launch of Spanish Website
9. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
10. RMAX International to donate Recuper8 - a free, health - restoring program to Everyone in Uniform
11. International symposium on veterinary rehabilitation and physical therapy to be held in Vienna
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... Tenn. (PRWEB) , ... July 01, 2015 , ... The ... held rain or shine Saturday, July 11, 2015, at 6 p.m. in Pugh Bourne ... free and includes pony rides, a petting zoo, an Elvis impersonator, a silent auction ...
(Date:7/1/2015)... ... 2015 , ... “Well-meaning social policy often has unintended and ... School of International and Public Affairs. , The researchers examined longitudinal ... Survey on Drug Use and Health, which is a nationally representative survey of ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... IBM software products, announced today that it has received trademark protection for its ... and detailed analysis of data from multiple sources providing an environment where users ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... big summer sale. Customers purchasing two or more Bunion Booties directly from ... , Bunion Bootie temporarily corrects misaligned toes and its ultra thin properties ...
(Date:7/1/2015)... ... July 01, 2015 , ... B. E. Smith, the ... to lead a national chief executive officer recruitment for Citizens Medical ... healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare executives ...
Breaking Medicine News(10 mins):Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 2Health News:Citizens Medical Center Retains B. E. Smith to Recruit New CEO 3
... Md. and ST. PAUL, Minn., Feb. 29 /PRNewswire-USNewswire/,-- ... Society &,Family Services, application for full Hague Accreditation ... This achievement of Hague,Accreditation demonstrates CHSFS, commitment to ... and abroad., The Hague Convention on Protection ...
... 29 The California,Academy of Physician Assistants (CAPA) announced ... elected as Speaker of the,California State Assembly. Bass, a ... is a former faculty member at the,University of Southern ... the California Assembly in 2004., As a physician ...
... Patient,Safety Foundation,s theme this year, "Patient Safety -- ... healthcare as a joint,effort of hospitals, healthcare providers, ... Awareness Week, March 2-8, 2008,medical device manufacturer Encision ... partner with local hospitals to promote patient safety., ...
... 29 Par,Pharmaceutical Companies, Inc. (NYSE: PRX ) ... December 31, 2007., Fourth Quarter and 2007 Results, ... Par reported total,revenues of $155.1 million and income from ... This is compared with reported,revenues of $183.6 million and ...
... Company for Healthcare Innovation, Creating Local Jobs, ... Tsongas visited local medical device manufacturer,NxStage Medical, Inc., ... Medical is a growing public company whose novel ... failure to have hemodialysis,treatment at home or where ...
... ... growth of EMR business, MARKHAM, ON, Feb. 29 ... NGH), one of North,America,s fastest growing healthcare software and ... business to Netsmart,Technologies Inc., a leading provider of enterprise-wide ...
Cached Medicine News:Health News:Children's Home Society & Family Services Achieves Full Hague Accreditation 2Health News:Physician Assistant Karen Bass Elected Speaker Elect of California State Assembly 2Health News:Encision Supports National Patient Safety Awareness Week 2Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 2Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 3Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 4Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 5Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 6Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 7Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 8Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 9Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 10Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 11Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 12Health News:Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results 13Health News:Tsongas Visits Lawrence-based Medical Device Maker NxStage Medical, Inc. 2Health News:Nightingale announces US$12.3 million sale of its Therapist Helper business 2Health News:Nightingale announces US$12.3 million sale of its Therapist Helper business 3Health News:Nightingale announces US$12.3 million sale of its Therapist Helper business 4
(Date:7/1/2015)... DALLAS , July 1, 2015 ... Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, ... Protein Production) - Analysis & Global Forecast to 2020", ... is expected to reach around $957.9 Million by 2020 ... Browse 116 market T ables ...
(Date:7/1/2015)... -- Celsion Corporation (NASDAQ: CLSN ), an oncology drug ... , Chairman, President and CEO, is scheduled to present ... July 8, 2015, at 4:15 p.m. Eastern Time. The conference ... at 119 W. 56th Street, New York ... the presentation will be available in the Events & ...
(Date:7/1/2015)... Radiant Insights announce that it ... Market Shares, Strategy, and Forecasts, Worldwide, 2015 to ... as the aging population worldwide needs homecare oxygen treatment. ... oxygen is able to improve the quality of the ... affordable and support a mobile lifestyle even while on ...
Breaking Medicine Technology:Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 2Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 3Transfection Reagents and Equipment Market Worth $957.9 Million by 2020 4Celsion Corporation to Present at Cantor Fitzgerald's Inaugural Healthcare Conference on July 8, 2015 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 2Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 3Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc. 4
... Than for Asthma,Rheumatoid Arthritis and Migraines, WAYNE, Pa., ... of,four ulcerative colitis (UC) sufferers (73 percent) responding ... has become a normal part,of life. Furthermore, they ... relationship with a spouse (64 percent), their sexual,relations ...
... - Results,published this week in The Lancet show ... (Types 6, 11,16, 18) Recombinant Vaccine) was 100 ... caused by HPV,types 16 and 18, two types ... was observed in women who were not,infected with ...
Cached Medicine Technology:Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 2Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 3Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 4Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 5Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 6Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 7Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 8Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 9Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 10Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 11Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 12Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 13Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 14Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 15Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 16Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 17Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 18Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 19Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 20Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 21Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 22Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 23Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 24Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 25Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 26Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 27Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18 28
... Simplex™ P with Tobramycin ... Bone Cement formula, with the ... By maintaining the original formula, ... performance characteristics of Simplex™ P ...
... Flow Analyzer is a fast, clinically proven ... of low and normal-tension glaucoma., ,The Ocular ... clinically proven measurement that improves detection of ... management of glaucoma, and detection of other ...
... Flexible Dosposable Easy Insertion/Removal ... (CSS) provides absolutely reliable support to ... thereby permitting routine phacoemulsification regardless of ... easy (similar to disposable iris retractors), ...
The collagen intracanicular plugs have a smooth proprietary finish that simplifies insertion of the plug. Collagen plugs are ideal for short term, diagnostic and post-surgical occlusion. Plugs are 2m...
Medicine Products: